Department of Cardiology and Cardiovascular Medicine, Universität Tübingen, Otfried-Müller-Strasse 10, 72076 Tübingen, Germany.
Institute of Pharmaceutical Sciences, Universität Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
Eur Heart J. 2017 Jul 1;38(25):1993-2005. doi: 10.1093/eurheartj/ehx146.
Hyperlipidaemia enhances susceptibility to thrombosis, while platelet oxidixed LDL (oxLDL) binding in acute coronary syndrome (ACS) correlates with activation status. This study explores the platelet lipidome in symptomatic coronary artery disease (CAD) patients and the functional consequences of the chemokine CXCL12 and its receptors CXCR-4/-7 on lipid uptake in platelets.
Platelet-oxLDL detected by flow cytometry was enhanced (P = 0.04) in CAD patients, moderately correlated with platelet CXCR7 surface expression (ρ = 0.39; P < 0.001), while inversely with CXCR4 (ρ = 0.35; P < 0.001). Platelet-oxLDL was elevated (P = 0.01) in ACS patients with angiographic evidence of intracoronary thrombi. Ex vivo analysis of intracoronary thrombi sections revealed oxLDL deposition in platelet-enriched areas verified by immunofluorescence confocal microscopy. LDL-oxLDL uptake enhanced reactive oxygen species, mitochondrial superoxide generation, intraplatelet LDL to oxLDL conversion, and lipid peroxidation, counteracted by SOD2-mimetic MnTMPyP. Lipidomic analysis revealed enhanced intraplatelet-oxidized phospholipids, cholesteryl esters, sphingomyelin, ceramides, di- and triacylglycerols, acylcarnitines in CAD patients compared with age-matched controls as ascertained by liquid chromatography hyphenated to high-resolution mass spectrometry. LDL-oxLDL induced degranulation, αIIbβ3-integrin activation, apoptosis, thrombin generation estimated by calibrated automated thrombinoscopy, and shape change verified by live imaging using scanning ion conductance microscopy. Further, LDL-oxLDL enhanced thrombus formation ex vivo and in vivo in mice (ferric chloride-induced carotid artery injury). LDL-oxLDL enhanced platelet CXCL12 release, differentially regulated CXCR4-CXCR7 surface exposure, while CXCL12 prompted LDL-oxLDL uptake and synergistically augmented the LDL-oxLDL-induced pro-oxidative, thrombogenic impact on platelet function.
An altered platelet lipidome might be associated with thrombotic disposition in CAD, a mechanism potentially regulated by CXCL12-CXCR4-CXCR7 axis.
高脂血症增加血栓形成的易感性,而急性冠状动脉综合征(ACS)中血小板氧化型 LDL(oxLDL)结合与激活状态相关。本研究探讨了有症状的冠状动脉疾病(CAD)患者的血小板脂质组学,以及趋化因子 CXCL12 及其受体 CXCR-4/-7 对血小板脂质摄取的功能后果。
流式细胞术检测到 CAD 患者的血小板-oxLDL 增强(P=0.04),与血小板 CXCR7 表面表达中度相关(ρ=0.39;P<0.001),而与 CXCR4 呈负相关(ρ=0.35;P<0.001)。在有冠状动脉内血栓形成的 ACS 患者中,血小板-oxLDL 升高(P=0.01)。对冠状动脉内血栓的体外分析显示,免疫荧光共聚焦显微镜证实 oxLDL 沉积在富含血小板的区域。LDL-oxLDL 摄取增强了活性氧、线粒体超氧化物生成、血小板内 LDL 向 oxLDL 的转化和脂质过氧化,这一过程被 SOD2 模拟物 MnTMPyP 拮抗。脂质组学分析显示,与年龄匹配的对照组相比,CAD 患者的血小板内氧化磷脂、胆固醇酯、鞘磷脂、神经酰胺、二酰基和三酰基甘油、酰基辅酶 A 增加,这一点通过液相色谱与高分辨率质谱联用得到证实。LDL-oxLDL 诱导脱颗粒、αIIbβ3 整合素激活、凋亡、通过校准自动凝血镜测定的凝血酶生成以及通过扫描离子电导显微镜的活细胞成像证实的形态变化。此外,LDL-oxLDL 增强了体内外的小鼠血栓形成(三氯化铁诱导的颈动脉损伤)。LDL-oxLDL 增强了血小板 CXCL12 的释放,调节了 CXCR4-CXCR7 表面暴露的差异,而 CXCL12 促进了 LDL-oxLDL 的摄取,并协同增强了 LDL-oxLDL 对血小板功能的促氧化、促血栓形成作用。
改变的血小板脂质组可能与 CAD 中的血栓形成倾向有关,这一机制可能受 CXCL12-CXCR4-CXCR7 轴调节。